FDA Approved: * July 10, 1974
Pharm Company: * SANDOZ
Category: Diabetes

Tolbutamide is a first-generation potassium channel blocker, sulfonylurea oral hypoglycemic medication. This drug may be used in the management of type 2 diabetes if diet alone is not effective. Tolbutamide stimulates the secretion of insulin by the pancreas. It is not routinely used due to a higher incidence of adverse effects compared to newer, second-generation sulfonylureas, such as Glibenclamide. It generally has a short duration of action due to its rapid metabolism, so is safe for use ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tolbutamide M;13
Tolbutamide 500 mg Oral Tablet
NDC: 0378-0215
Mylan Pharmaceuticals Inc.

Related Brands

Drugs with the same active ingredients